Cellbless Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 10-12-2024
- Revenue 85.78%
(FY 2022)
- Profit 85.19%
(FY 2022)
- Ebitda -1993.64%
(FY 2022)
- Net Worth 105.80%
(FY 2022)
- Total Assets -1.07%
(FY 2022)
About Cellbless Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Ajit Bhatt and Vikas Bhatt serve as directors at the Company.
- CIN/LLPIN
U74120UP2015PTC073988
- Company No.
073988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cellbless Healthcare Private Limited offer?
Cellbless Healthcare Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Medical Laboratory Instruments, Corona Test Kit, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Bed Linen & Bedspreads, Bedding Set, Hospital and Medical Furniture, Hospital Equipment.
Who are the key members and board of directors at Cellbless Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Bhatt  | Director | 20-Oct-2015 | Current |
| Ajit Bhatt | Director | 20-Oct-2015 | Current |
Financial Performance of Cellbless Healthcare.
Cellbless Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 85.78% increase. The company also saw a substantial improvement in profitability, with a 85.19% increase in profit. The company's net worth Soared by an impressive increase of 105.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellbless Healthcare?
In 2020, Cellbless Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 May 2023 | ₹1.00 M | Open |
How Many Employees Work at Cellbless Healthcare?
Unlock and access historical data on people associated with Cellbless Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellbless Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellbless Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
